Sabbour HM - Search Results

1

First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population.

Iqbal S, Sabbour HM, Ashraf T, Santos RD, Buckley A. Iqbal S, et al. Among authors: sabbour hm. Clin Ther. 2024 Mar;46(3):186-193. doi: 10.1016/j.clinthera.2023.12.003. Epub 2024 Jan 14. Clin Ther. 2024. PMID: 38220483 Free article.

2

Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis.

Shehab A, Bhagavathula AS, Abebe TB, Abegaz TM, Elnour AA, Sabbour HM, Uzzafer M, Hersi A, Hamad AK. Shehab A, et al. Among authors: sabbour hm. Curr Vasc Pharmacol. 2019;17(4):341-349. doi: 10.2174/1570161116666180123111949. Curr Vasc Pharmacol. 2019. PMID: 29359674

3

Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.

Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Al-Ashwal A, et al. Curr Vasc Pharmacol. 2015;13(6):759-70. doi: 10.2174/1570161113666150827125040. Curr Vasc Pharmacol. 2015. PMID: 26311574 Free PMC article.

4

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet. 2021 Nov 6;398(10312):1713-1725. doi: 10.1016/S0140-6736(21)01122-3. Epub 2021 Sep 7. Lancet. 2021. PMID: 34506743

5

The First Report of a Real-world Experience With a PCSK9 Inhibitor in a Large Familial Hyperlipidemia and Very-high-risk Middle Eastern Population.

Iqbal S, Sabbour HM, Siddiqui MS, Tikriti AA, Santos RD, Buckley A. Iqbal S, et al. Among authors: sabbour hm. Clin Ther. 2022 Oct;44(10):1297-1309. doi: 10.1016/j.clinthera.2022.08.005. Epub 2022 Sep 17. Clin Ther. 2022. PMID: 36127165 Free article.

6

Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East.

Al Sayed N, Al Waili K, Alawadi F, Al-Ghamdi S, Al Mahmeed W, Al-Nouri F, Al Rukhaimi M, Al-Rasadi K, Awan Z, Farghaly M, Hassanein M, Sabbour H, Zubaid M, Barter P. Al Sayed N, et al. Int J Cardiol. 2016 Dec 15;225:268-283. doi: 10.1016/j.ijcard.2016.09.081. Epub 2016 Sep 28. Int J Cardiol. 2016. PMID: 27741487 Free article. Review.

7

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.

Alhabib KF, Al-Rasadi K, Almigbal TH, Batais MA, Al-Zakwani I, Al-Allaf FA, Al-Waili K, Zadjali F, Alghamdi M, Alnouri F, Awan Z, Kinsara AJ, AlQudaimi A, Almahmeed W, Sabbour H, Traina M, Atallah B, Al-Jarallah M, AlSarraf A, AlSayed N, Amin H, Altaradi H. Alhabib KF, et al. PLoS One. 2021 Jun 4;16(6):e0251560. doi: 10.1371/journal.pone.0251560. eCollection 2021. PLoS One. 2021. PMID: 34086694 Free PMC article.

8

Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.

Alsayed N, Almahmeed W, Alnouri F, Al-Waili K, Sabbour H, Sulaiman K, Zubaid M, Ray KK, Al-Rasadi K. Alsayed N, et al. Atherosclerosis. 2022 Feb;343:28-50. doi: 10.1016/j.atherosclerosis.2021.11.022. Epub 2021 Dec 10. Atherosclerosis. 2022. PMID: 35091265 Review.

9

A cross-sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT-MEA): Study design and rationale.

Verma S, Sabbour H, Alamuddin N, Alawadi F, Alkandari H, Almahmeed W, Assaad-Khalil SH, Haddad J, Lombard L, Malik RA, Mashaki Ceyhan E, Prasad P, Tombak G, Salek S. Verma S, et al. Diabetes Obes Metab. 2023 Jun;25(6):1444-1452. doi: 10.1111/dom.15011. Epub 2023 Mar 3. Diabetes Obes Metab. 2023. PMID: 36775980

10

The First Pulmonary Hypertension Registry in the United Arab Emirates (UAEPH): Clinical Characteristics, Hemodynamic Parameters with Focus on Treatment and Outcomes for Patients with Group 1-PH.

Saleh K, Khan N, Dougherty K, Bodi G, Michalickova M, Mohammed S, Kerenidi T, Sadik Z, Mallat J, Farha S, Sabbour H. Saleh K, et al. J Clin Med. 2023 Mar 2;12(5):1996. doi: 10.3390/jcm12051996. J Clin Med. 2023. PMID: 36902782 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters